IPO profile
Paras Healthcare
PARASHCL · NSE
- Price band
- Not available
- Subscription
- Not available
Application & Issue Details
- Minimum Quantity
- Not available
- Minimum Application
- Not available
- Issue Size
- Not available
- Face Value
- Not available
Company Overview
Paras Health is the fifth largest healthcare provider by bed capacity in North India, Bihar, and Jharkhand, with 2,135 beds across eight hospitals as of March 31, 2024. Focused on providing specialized tertiary care in Tier 2 and 3 cities, Paras Health offers clinical specialties like cardiac sciences, oncology, and orthopedics. With 18 years of experience, the company has an asset-light business model, successfully expanding into underserved markets. It has plans to increase bed capacity to 2,935 by 2029 through new hospitals in Gurugram and Ludhiana. Paras Health also invests in digital healthcare solutions.
Important Dates
- Open Date
- Not available
- Close Date
- Not available
- Allotment Date
- Not available
- Listing Date
- Not available
Grey Market Premium (GMP)
No GMP has been reported for this IPO. Estimates are not shown rather than assuming a GMP of zero.
Grey Market Premium (GMP) is unofficial and indicative. Actual listing price may differ.
Indicative Listing Estimate
Estimated listing figures need a GMP value, which is currently unavailable.
Subscription
Subscription data not available yet.
Company Strengths & Risks
Reported strengths
- One of the largest healthcare providers in underserved markets of North India, with a first-mover advantage in key regions.
- Asset-light business model focused on driving patient access and operational performance.
- Strong ability to attract and retain renowned clinicians, delivering high-quality clinical care.
- Diversified operations across multiple clinical specialties, payor mix, and geographic locations.
- Robust infrastructure with advanced information technology systems and modern medical equipment.
- Doctor-led professional management team with proven execution capabilities and deep industry expertise.
Key risks
- Incurred significant losses in recent years with no guarantee of future profitability.
- Reliant on attracting and retaining skilled healthcare professionals to maintain operations.
- Regulatory changes and pharmaceutical pricing uncertainties could harm financial performance.
- Dependence on in-patient revenue and occupancy rates affects profitability.
- Non-exclusive doctor arrangements risk disruption if key doctors leave.
- Non-compliance with regulations could severely impact business and finances.
Company strengths and risks are informational summaries. Review the offer document for complete disclosures.
Documents & Coverage
IPO data last updated 25 Oct 2026, 8:02 pm IST
This page is for informational and educational purposes only. It is not investment advice and not a recommendation to buy, sell, or apply for this IPO. GMP and subscription figures are unofficial/may change. Please make your own independent decision.